Friday, August 13, 2004 9:55:33 AM
"...thats why DNAP was the ONLY company that
could turn around the LA investagation."
A small correction, DNAP was the only company that 'did' turn around the LA investigation..."
The assumption that other companies 'couldn't' have developed the same kind of test is not viable. Realize that large companies with multimillion dollar budgets have the valuable luxury of being able to do market research 'before' they embark on new programs. DNAP, on the other hand, was forced by their size and economic limitations to gamble on the potential market for their product and develop it in the hope that a market would develop for it. In retrospect it may not have been a successful bet. It it doubtful that, given the present published income figures, DNAWitness will achieve 'breakeven' status for many months to come. In other words they will not even get back the money they spent on the development of the product, let alone make a profit.
That, of course is the risk involved in developing a new company, and is one of the main reason that most new start-up companies fail.
regards,
frog
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM